| Today's Open | $1.67 |
|---|---|
| Previous Close | $1.66 |
| Daily Range | $1.65 - $1.78 |
| 52-Week Range | $1.50 - $3.51 |
| Market Cap | $91.1M |
| P/E Ratio | -1.91 |
| Dividend (Yield) | $0.00 (0.0%) |
| Volume | 309,137 |
| Average Daily Volume | 584,491 |
| Current FY EPS | -$1.05 |
Sector
Healthcare
Industry
Drugs
Discovery Laboratories, Inc. (DSCO) Description
A biotechnology company, which develops its proprietary surfactant technology as Surfactant Replacement Therapies for respiratory disorders and diseases. Website: http://www.discoverylabs.com/
News & Commentary
Discovery Labs Issues Final Assessment of Reintubation on Healthcare Costs, Says Infants Treated wit
Discovery Labs Issues Final Assessment of Reintubation on Healthcare Costs, Says Infants Treated with Surfaxin Survival Higher without IntubationUPDATE: Discovery Labs Responds to FDA Request for Clarification of Recently Submitted SURFAXIN(R) (
UPDATE: Discovery Labs Responds to FDA Request for Clarification of Recently Submitted SURFAXIN(R) (lucinactant) Updated Product SpecificationsDiscovery Labs to Float Stock Issue
The company aims to raise net proceeds of more than $13 million in the issue.The FDA Issues a Stunning Rejection
Gilead receives a complete response letter for part of an already approved drug.Discovering Yet Another Drug Delay
This company is king when it comes to drug delays.DSCO's Top Competitors
(3.01%)
(0.85%)
(0.82%)
(-0.23%)